ClinicalTrials.Veeva

Menu

Obesity and Brain: Genes and Environment

A

Amsterdam UMC, location VUmc

Status

Completed

Conditions

Obesity

Study type

Observational

Funder types

Other

Identifiers

NCT02025595
DC2013ObesiBrain001
91613082 (Other Grant/Funding Number)
NL 44735.029.13 (Other Identifier)

Details and patient eligibility

About

The aim of this study is to investigate the effects of genetic and environmental risk factors on central nervous system (CNS) reward and satiety circuits in the etiology of obesity. The investigators will also investigate to what extent the alterations in CNS reward and satiety circuits are a cause or a consequence of the development of obesity.

Enrollment

92 patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 18-75 years
  • Male or female
  • Stable bodyweight (<5% reported weight change during previous 3 months)
  • Women: regular menstruation cycle (to exclude possible menstruation cycle effects)
  • Normal fasting blood glucose

Exclusion criteria

  • Left handedness
  • Known diabetes or abnormal fasting blood glucose
  • Serious heart, pulmonary, hepatic or renal disease, malignant or hematological disease
  • Metabolic disorders (uncontrolled adrenal/thyroid disease)
  • Women: irregular menstruation cycle
  • Neurological or psychiatric illness
  • Pregnancy or breast feeding
  • Alcohol abuse
  • Nicotine abuse
  • Claustrophobia or metal implants
  • Visual disability
  • Participation in another study
  • Inability to understand the protocol or to give informed consent
  • Current/chronic use of following medication: antihyperglycemic agents, glucocorticoids, centrally acting drugs, cytostatics, immune suppressants, potentially addictive medications.

Trial design

92 participants in 2 patient groups

Monozygotic twin pairs
Description:
15 monozygotic twin pairs discordant for obesity
Genetic predisposition for obesity
Description:
15 obese and 15 non-obese individuals with a high genotype obesity risk score and 15 obese and 15 non-obese individuals with a low genotype obesity risk score. Genotype obesity risk score will be based on genome wide association single-nucleotide polymorphisms (SNP's) associated with obesity.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems